Credit Suisse’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.25M Sell
36,987
-259
-0.7% -$8.75K ﹤0.01% 2127
2023
Q4
$1.17M Sell
37,246
-7,607
-17% -$240K ﹤0.01% 2230
2023
Q3
$1.15M Sell
44,853
-16,693
-27% -$427K ﹤0.01% 2207
2023
Q2
$1.77M Buy
61,546
+18,571
+43% +$533K ﹤0.01% 1981
2023
Q1
$1.03M Buy
42,975
+5,451
+15% +$131K ﹤0.01% 2293
2022
Q4
$636K Buy
37,524
+4,437
+13% +$75.3K ﹤0.01% 2614
2022
Q3
$490K Buy
33,087
+8,309
+34% +$123K ﹤0.01% 2772
2022
Q2
$390K Sell
24,778
-863
-3% -$13.6K ﹤0.01% 2984
2022
Q1
$692K Sell
25,641
-363
-1% -$9.8K ﹤0.01% 2768
2021
Q4
$963K Buy
26,004
+1,433
+6% +$53.1K ﹤0.01% 2611
2021
Q3
$1.17M Buy
24,571
+12,788
+109% +$611K ﹤0.01% 2473
2021
Q2
$398K Sell
11,783
-2,919
-20% -$98.6K ﹤0.01% 3150
2021
Q1
$607K Sell
14,702
-34,829
-70% -$1.44M ﹤0.01% 2846
2020
Q4
$2.15M Sell
49,531
-26,030
-34% -$1.13M ﹤0.01% 2082
2020
Q3
$3.24M Buy
75,561
+59,346
+366% +$2.54M ﹤0.01% 1519
2020
Q2
$757K Sell
16,215
-3,144
-16% -$147K ﹤0.01% 2471
2020
Q1
$263K Sell
19,359
-39,644
-67% -$539K ﹤0.01% 2901
2019
Q4
$641K Buy
+59,003
New +$641K ﹤0.01% 2781
2017
Q1
Sell
-1,972
Closed -$29K 3416
2016
Q4
$29K Sell
1,972
-9,999
-84% -$147K ﹤0.01% 3690
2016
Q3
$207K Buy
11,971
+3,388
+39% +$58.6K ﹤0.01% 3456
2016
Q2
$270K Buy
8,583
+91
+1% +$2.86K ﹤0.01% 3439
2016
Q1
$225K Buy
8,492
+2,243
+36% +$59.4K ﹤0.01% 3343
2015
Q4
$275K Buy
+6,249
New +$275K ﹤0.01% 3506
2014
Q4
Sell
-7,860
Closed -$850K 4184
2014
Q3
$850K Buy
7,860
+5,997
+322% +$649K ﹤0.01% 2831
2014
Q2
$226K Buy
1,863
+220
+13% +$26.7K ﹤0.01% 3859
2014
Q1
$209K Buy
+1,643
New +$209K ﹤0.01% 3952